Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus
ObjectivesRed ginseng is a processed product of Panax ginseng C.A. Meyer, which is one of the widely used medicinal and edible herbs for the treatment of type 2 diabetes mellitus (T2DM). Ginsenosides are its main pharmacologically active ingredient. This study aims to clarify the material basis of t...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.865070/full |
_version_ | 1818249286360498176 |
---|---|
author | Rensong Huang Meng Zhang Yu Tong Yaran Teng Hui Li Wei Wu |
author_facet | Rensong Huang Meng Zhang Yu Tong Yaran Teng Hui Li Wei Wu |
author_sort | Rensong Huang |
collection | DOAJ |
description | ObjectivesRed ginseng is a processed product of Panax ginseng C.A. Meyer, which is one of the widely used medicinal and edible herbs for the treatment of type 2 diabetes mellitus (T2DM). Ginsenosides are its main pharmacologically active ingredient. This study aims to clarify the material basis of total ginsenosides of red ginseng (RGW) and verify the activity of RGW in treating lipid metabolism disorders caused by T2DM.MethodsAn ultrahigh performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UHPLC-Q-TOF-MS) technology was applied to quantitatively analyze RGW. A T2DM rat model was established to verify the activity of RGW in treating lipid metabolism disorders caused by diabetes. First, the changes in diabetes-related parameters were observed, then the biochemical parameters of the rat serum and liver were measured, and finally, the pathological sections of the rat liver were observed, and the content of short-chain fatty acids in stools was measured. The in vitro activity of RGW was verified by fatty degenerated HepG2 cells.ResultsA total of 10 ginsenosides were identified and quantitatively analyzed in RGW. Experimental results demonstrated that RGW can improve lipid metabolism disorders. RGW significantly reduced the fasting blood glucose and TG and TC levels in T2DM rats, and hepatic steatosis was significantly ameliorated. In vitro experiments by RGW treatment also significantly attenuated lipid deposition in HepG2 cells. RGW upregulated the content of 5 short-chain fatty acids in rat stools, which are related to lipid oxidation and liver gluconeogenesis.ConclusionThe total RGW were quantitatively analyzed by UHPLC-MS, and its effect on lipid metabolism of T2DM was studied. The experiment demonstrated that red ginseng can regulate lipid metabolism and improve lipid deposition, which provides a promising development for red ginseng as a functional food. |
first_indexed | 2024-12-12T15:34:05Z |
format | Article |
id | doaj.art-3121ee4102b84d799990983f39798152 |
institution | Directory Open Access Journal |
issn | 2296-861X |
language | English |
last_indexed | 2024-12-12T15:34:05Z |
publishDate | 2022-04-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Nutrition |
spelling | doaj.art-3121ee4102b84d799990983f397981522022-12-22T00:20:03ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2022-04-01910.3389/fnut.2022.865070865070Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes MellitusRensong HuangMeng ZhangYu TongYaran TengHui LiWei WuObjectivesRed ginseng is a processed product of Panax ginseng C.A. Meyer, which is one of the widely used medicinal and edible herbs for the treatment of type 2 diabetes mellitus (T2DM). Ginsenosides are its main pharmacologically active ingredient. This study aims to clarify the material basis of total ginsenosides of red ginseng (RGW) and verify the activity of RGW in treating lipid metabolism disorders caused by T2DM.MethodsAn ultrahigh performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UHPLC-Q-TOF-MS) technology was applied to quantitatively analyze RGW. A T2DM rat model was established to verify the activity of RGW in treating lipid metabolism disorders caused by diabetes. First, the changes in diabetes-related parameters were observed, then the biochemical parameters of the rat serum and liver were measured, and finally, the pathological sections of the rat liver were observed, and the content of short-chain fatty acids in stools was measured. The in vitro activity of RGW was verified by fatty degenerated HepG2 cells.ResultsA total of 10 ginsenosides were identified and quantitatively analyzed in RGW. Experimental results demonstrated that RGW can improve lipid metabolism disorders. RGW significantly reduced the fasting blood glucose and TG and TC levels in T2DM rats, and hepatic steatosis was significantly ameliorated. In vitro experiments by RGW treatment also significantly attenuated lipid deposition in HepG2 cells. RGW upregulated the content of 5 short-chain fatty acids in rat stools, which are related to lipid oxidation and liver gluconeogenesis.ConclusionThe total RGW were quantitatively analyzed by UHPLC-MS, and its effect on lipid metabolism of T2DM was studied. The experiment demonstrated that red ginseng can regulate lipid metabolism and improve lipid deposition, which provides a promising development for red ginseng as a functional food.https://www.frontiersin.org/articles/10.3389/fnut.2022.865070/fullred ginsengUHPLC-MStype 2 diabetes mellituslipid metabolismshort-chain fatty acids |
spellingShingle | Rensong Huang Meng Zhang Yu Tong Yaran Teng Hui Li Wei Wu Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus Frontiers in Nutrition red ginseng UHPLC-MS type 2 diabetes mellitus lipid metabolism short-chain fatty acids |
title | Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus |
title_full | Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus |
title_fullStr | Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus |
title_full_unstemmed | Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus |
title_short | Studies on Bioactive Components of Red Ginseng by UHPLC-MS and Its Effect on Lipid Metabolism of Type 2 Diabetes Mellitus |
title_sort | studies on bioactive components of red ginseng by uhplc ms and its effect on lipid metabolism of type 2 diabetes mellitus |
topic | red ginseng UHPLC-MS type 2 diabetes mellitus lipid metabolism short-chain fatty acids |
url | https://www.frontiersin.org/articles/10.3389/fnut.2022.865070/full |
work_keys_str_mv | AT rensonghuang studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus AT mengzhang studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus AT yutong studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus AT yaranteng studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus AT huili studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus AT weiwu studiesonbioactivecomponentsofredginsengbyuhplcmsanditseffectonlipidmetabolismoftype2diabetesmellitus |